Cohera Medical

A rapidly growing medical device company actively developing surgical adhesives and sealants.

Learn More

TissuGlu Surgical Adhesive

Eliminate the need for postsurgical drains in most abdominoplasty (tummy tuck) surgeries.

Learn More

Sylys Surgical Sealant

Designed to help reduce anastomotic leakage in gastrointestinal surgical procedures.

Learn More

About Cohera Medical

Cohera Medical, Inc. is a rapidly growing, US based medical device company actively developing surgical adhesives and sealants. TissuGlu Surgical Adhesive, the first synthetic adhesive approved for internal use, is an easily applied biocompatible, resorbable adhesive that requires no mixing or thawing. Indicated for the approximation of tissue layers where subcutaneous dead space exists between tissue planes in abdominoplasty, TissuGlu Surgical Adhesive has been shown to eliminate the need for postoperative surgical drains in most abdominoplasty procedures.

Latest News

Drain-Free Mastectomy with TissuGlu® Surgical Adhesive presented at UK Breast Surgery meeting

Review of previous reports from Germany presented at UK Association of Breast Surgery (ABS) meeting in Belfast RALEIGH, N.C., May 24, 2017 — The potential of drain-free mastectomy attracted wide attention at the UK meeting of the Association of Breast Surgeons (ABS...
Read More

Executive-Level Specialty Medical and Biopharmaceutical Sales Management Professional Joins Cohera Medical, Inc.®

John Wyatt, a Nashville-area sales leader with 20+ years of experience launching, marketing and selling aesthetic medical devices, joined the Cohera Medical, Inc. sales team. RALEIGH, NC, February 16, 2017 – Cohera Medical, Inc., a leading innovator and developer of...
Read More

Breakthrough Surgical Sealant Designed to Help Reduce Anastomotic Leaks for Patients Undergoing Colorectal Surgery

Cohera Medical, Inc.® Enrolls First Patient in Clinical Trial of its Sylys® Surgical Sealant in the U.S RALEIGH, NC, January 03, 2017 – Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has...
Read More

TissuGlu® Surgical Adhesive helps reduce hospital stays for patients with pressure sores

New study on surgical repair of advanced pressure sores (decubitis ulcer) shows >50% reduction in revision surgery and an 8 day reduction in length of stay RALEIGH, NC, November 29, 2016 - A recent German study published in Journal of Spine (Kuhfuss I, J Spine...
Read More

Cohera Medical, Inc.® Appoints Paul Thomas to its Board of Directors

29 July 2016 Cohera Medical, Inc.,  a leading innovator and developer of absorbable surgical adhesives and sealants, announced today the appointment of Paul Thomas as a member of its Board of Directors. “We are honored to welcome Paul Thomas to our Board of Directors...
Read More

Cohera Medical, Inc.® Receives FDA Approval to Begin Clinical Trials of its Sylys® Surgical Sealant in the U.S.

12 July 2016 Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) to begin...
Read More

North Carolina Plastic Surgeon First to Use New Surgical Adhesive Commercially in the U.S.

PITTSBURGH, PA – November 5, 2015 – As part of TissuGlu® Surgical Adhesive’s U.S. commercial launch this week, Cohera Medical, Inc.® is announcing Dr. Joseph Hunstad, board-certified plastic surgeon and co-founder of Hunstad Kortesis Plastic Surgery + MedSpa located...
Read More

Cohera Medical, Inc.® Announces $50 Million in New Financing

PITTSBURGH, PA., October 21, 2015 – Cohera Medical, a leading innovator and developer of absorbable surgical adhesives and sealants, announced closing the first tranche of a $50 million equity financing led by KKR, a leading global investment firm, with participation...
Read More

Cohera Medical Receives CE Marking Approval for Sylys® Surgical Sealant

PITTSBURGH, Pa., August 13, 2015 – Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received CE Marking approval for Sylys® Surgical Sealant, the first synthetic sealant designed...
Read More

Cohera Medical, Inc.® Receives Expedited Access Pathway Designation from FDA for Sylys® Surgical Sealant

PITTSBURGH, June 9, 2015 /PRNewswire/—Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that its Sylys® Surgical Sealant has received Expedited Access Pathway (EAP) designation and priority...
Read More

Get Updates

Join our mailing list to be among the first to receive updates about new product developments and other news from Cohera Medical.

Sign Up Now

Cohera Medical Corporate Headquarters

227 Fayetteville Street
Suite 900
Raleigh, NC 27601, USA
Phone: 1-800-641-7458
Email – cs@coheramed.com

Cohera Medical, Inc.

c/o HealthLink Europe
De Tweeling 20-22
‘s-Hertogenbosch 5215 MC
The Netherlands

Tel: +31-(0)73-3030500
Fax: +31-(0)13-5479301
Email: cs@healthlinkeurope.com

MKT-0004-EN REV G